Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes

OBJECTIVES: DRAKO (NCT02850263) is a 24-month, prospective, non-interventional, multi-centre cohort study which enroled patients diagnosed with centre-involving diabetic macular oedema (DMO). The study aims to evaluate standard of care with intravitreal aflibercept (IVT-AFL) treatment in the UK. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727562/
https://www.ncbi.nlm.nih.gov/pubmed/34244670
http://dx.doi.org/10.1038/s41433-021-01624-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727562/
https://www.ncbi.nlm.nih.gov/pubmed/34244670
http://dx.doi.org/10.1038/s41433-021-01624-9

Ejemplares similares